Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine
2012 · Molecular Therapy · 90 citations
https://doi.org/10.1038/mt.2012.128
F
Fabrice Le Bœuf
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
4.8K
Citations
31
h-index
42
i10-index
Fabrice Le Bœuf is an academic researcher. The author has contributed to research in topics: Virus-based gene therapy research & CAR-T cell therapy research & Viral Infections and Outbreaks Research. The author has an h-index of 31, co-authored 58 publications.
ORCID: 0000-0003-3706-2304Papers by this author
worksViral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy
2020 · Molecular Therapy — Oncolytics · 74 citations
https://doi.org/10.1016/j.omto.2020.03.018
Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models
2017 · Molecular Therapy — Oncolytics · 52 citations
https://doi.org/10.1016/j.omto.2017.08.001
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy
2019 · Molecular Therapy — Oncolytics · 32 citations
https://doi.org/10.1016/j.omto.2019.06.004
First-in-class small molecule potentiators of cancer virotherapy
2016 · Scientific Reports · 30 citations
https://doi.org/10.1038/srep26786
Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity
2013 · Blood Cancer Journal · 19 citations
https://doi.org/10.1038/bcj.2013.23
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat